About Theravance Biopharma
OUR FOCUS IS ON MAKING A DIFFERENCE
Theravance Biopharma, Inc.’s focus is to deliver Medicines that Make a Difference® in people’s lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its pipeline of internally discovered programs is targeted to address significant unmet patient needs.
Our Strategic Anchors
Focus on Insight and Innovation
Outsource Non-core Processes
Create and Foster an Integrated Environment
Aggressively Manage Uncertainty